EHealth Research Development from 2010 to 2026

EHTH Stock  USD 1.75  0.11  6.71%   
EHealth's Research Development is increasing with slightly volatile movements from year to year. Research Development is predicted to flatten to about 38.1 M. For the period between 2010 and 2026, EHealth, Research Development quarterly trend regression had mean deviation of  16,894,089 and range of 76.3 M. View All Fundamentals
 
Research Development  
First Reported
2004-03-31
Previous Quarter
11.4 M
Current Value
11.8 M
Quarterly Volatility
12.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check EHealth financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among EHealth's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.7 M, Interest Expense of 13.5 M or Selling General Administrative of 108.4 M, as well as many indicators such as Price To Sales Ratio of 0.57, Dividend Yield of 0.0138 or PTB Ratio of 0.4. EHealth financial statements analysis is a perfect complement when working with EHealth Valuation or Volatility modules.
  
Build AI portfolio with EHealth Stock
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
The Research Development trend for eHealth offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether EHealth is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest EHealth's Research Development Growth Pattern

Below is the plot of the Research Development of eHealth over the last few years. It is EHealth's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in EHealth's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

EHealth Research Development Regression Statistics

Arithmetic Mean43,911,034
Geometric Mean38,465,560
Coefficient Of Variation47.36
Mean Deviation16,894,089
Median38,058,585
Standard Deviation20,795,640
Sample Variance432.5T
Range76.3M
R-Value0.73
Mean Square Error212.5T
R-Squared0.54
Significance0.0008
Slope3,024,605
Total Sum of Squares6919.3T

EHealth Research Development History

202638.1 M
202561.5 M
202453.5 M
202361 M
202278.8 M
202183.8 M
202065.2 M

About EHealth Financial Statements

Investors use fundamental indicators, such as EHealth's Research Development, to determine how well the company is positioned to perform in the future. Although EHealth's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development61.5 M38.1 M

Currently Active Assets on Macroaxis

When determining whether eHealth offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EHealth's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ehealth Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ehealth Stock:
Check out the analysis of EHealth Correlation against competitors.
For more detail on how to invest in EHealth Stock please use our How to Invest in EHealth guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is there potential for Insurance Brokers market expansion? Will EHealth introduce new products? Factors like these will boost the valuation of EHealth. Projected growth potential of EHealth fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about EHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.976
Earnings Share
0.15
Revenue Per Share
17.986
Quarterly Revenue Growth
(0.08)
Return On Assets
0.0335
The market value of eHealth is measured differently than its book value, which is the value of EHealth that is recorded on the company's balance sheet. Investors also form their own opinion of EHealth's value that differs from its market value or its book value, called intrinsic value, which is EHealth's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because EHealth's market value can be influenced by many factors that don't directly affect EHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between EHealth's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding EHealth should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, EHealth's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.